Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid

Clinical Nuclear Medicine

Volumn 24, Issue 11, 1999, Pages 849-851

  Koerber, Carsten ^a   Schmutzler, Conny ^a   Rendl, Johann ^a   Koehrle, Josef ^a   Griesser, H ^a   Simon, Dietmar ^b   Reiners, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Differentiation Factors; Na+ I Sympoiter; Radioiodine Treatment; Retinoic Acid Therapy; Thyroid Carcinoma; Type I 5' deiodinase

Indexed keywords

DOXORUBICIN; IODINE 131; ISOTRETINOIN; PACLITAXEL; RETINOIC ACID;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CELL DIFFERENTIATION; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; IODINE 131 UPTAKE TEST; MALE; METASTASIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR BIOPSY;

CARCINOMA, PAPILLARY; HUMANS; IODINE RADIOISOTOPES; ISOTRETINOIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS;

EID: 0032750701     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199911000-00005     Document Type: Article

References (2)

1. Simon D, Koehrle J, Reiners C, et al: Redifferentiation therapy with retinoid: Therapeutic option for advanced follicular and papillary thyroid carcinoma. World J Surg 22:569, 1990.
2. Winzer R, Schmutzler C, Jakobs T, et al: RT-PCR analysis of thyreocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid 8:981, 1998.